2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 1.035.352 | 1.392.943 | 1.592.076 | 1.509.055 | 1.369.404 | 1.243.721 | 1.246.173 | 1.098.210 | 1.168.068 | 1.576.046 |
Total Income - EUR | 1.035.408 | 1.393.009 | 1.592.719 | 1.509.112 | 1.370.726 | 1.243.910 | 1.246.980 | 1.100.752 | 1.168.071 | 1.578.326 |
Total Expenses - EUR | 1.032.255 | 1.386.552 | 1.575.446 | 1.454.396 | 1.318.529 | 1.187.369 | 1.196.121 | 1.057.182 | 1.112.681 | 1.538.732 |
Gross Profit/Loss - EUR | 3.154 | 6.457 | 17.273 | 54.716 | 52.197 | 56.541 | 50.859 | 43.570 | 55.390 | 39.593 |
Net Profit/Loss - EUR | 694 | 4.593 | 13.554 | 43.880 | 43.205 | 47.339 | 42.637 | 37.094 | 45.957 | 32.586 |
Employees | 11 | 18 | 17 | 17 | 17 | 11 | 12 | 12 | 12 | 12 |
Check the financial reports for the company - Blue Pharm Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 18.078 | 28.349 | 31.120 | 22.734 | 16.456 | 13.697 | 18.474 | 9.750 | 6.758 | 3.349 |
Current Assets | 731.642 | 603.027 | 851.795 | 524.517 | 561.200 | 502.757 | 632.433 | 511.676 | 615.384 | 815.881 |
Inventories | 359.035 | 317.891 | 305.310 | 302.600 | 330.835 | 293.862 | 278.615 | 274.755 | 378.833 | 422.792 |
Receivables | 360.268 | 225.085 | 534.797 | 206.154 | 214.183 | 199.085 | 351.767 | 225.332 | 224.399 | 350.858 |
Cash | 12.340 | 60.051 | 11.689 | 15.763 | 16.182 | 9.809 | 2.051 | 11.589 | 12.152 | 42.230 |
Shareholders Funds | 961 | 5.563 | 13.821 | 26.141 | 68.866 | 114.872 | 126.388 | 141.528 | 29.525 | 62.022 |
Social Capital | 223 | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 |
Debts | 748.759 | 649.320 | 869.093 | 521.110 | 508.789 | 401.582 | 524.519 | 397.738 | 598.092 | 782.842 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4773 - 4773" | |||||||||
CAEN Financial Year |
4773
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Blue Pharm Srl